glp-1 for ckd Receptor Agonists and Diabetic Kidney Disease: A Call of Attention to Nephrologists GLP-1 therapy CKD - Diabetes

This article clarifies the relationship between fast food consumption and GLP-1 medication effectiveness, offering evidence-based guidance for optimal outcomes

Cabandugama said many of his patients typically paid around $1,500 a month out of pocket for brand names Wegovy and Zepbound, but in recent months theyve been able to get the same doses for around $400 a month or higher doses for around $500

Thats especially concerning for female athletes, many of whom may already be at risk for relative energy deficiency in sport (RED-S) or female athlete triad, a condition that typically includes under-eating, missing periods, and low bone mineral density

A separate trial of people with type 2 diabetes showed similar patterns: participants on semaglutide lost approximately 10 to 14 percent of body weight over one year

The observation that the induced effect on insulin secretion is different when oral glucose was administered versus the same amount of glucose parenterally coined the term incretin effect, supporting the idea that some substances secreted in the intestines favored the release of insulin after ingestion [1]